Last edition
News about Global Pharma
Global Pharma | 30/12/2022 | By Sudeep Soparkar | 809
Advent International to pick up 50.1% in Suven Pharma for Rs 6,313 Cr
The buyout is part of the private equity firm’s plan to create a contract drug manufacturing powerhouse in India
Global Pharma | 27/12/2022 | By Sudeep Soparkar | 872
KBI Biopharma secures Swissmedic Regulatory Establishment License for Geneva facility
The license allows KBI to fully support clients in their next phases of growth and certifies KBI's manufacturing capabilities in a cGMP environment
Global Pharma | 26/12/2022 | By Sudeep Soparkar | 944
Florida-based Formulated Solutions to buy Merck & Co and Bayer manufacturing facility
The manufacturing facility is located in Cleveland, Tennessee
Global Pharma | 21/12/2022 | By Sudeep Soparkar | 1321
JB Pharma to acquire the entire Razel (Rosuvastatin) franchise for Rs. 314 crores
The acquisition marks JB Pharma’s entry into the ‘Statin’ segment which is the largest group in the cardiac therapy. Razel ranks among the top 10 brands in the Rosuvastatin molecule category in the country <br />
Global Pharma | 15/12/2022 | By Sudeep Soparkar | 699
Lupin appoints Spiro Gavaris as President of US generics biz
Gavaris will be responsible for the overall strategy, implementation and growth of Lupin’s US Generics business
Global Pharma | 09/12/2022 | By Sudeep Soparkar | 480
Akums enters into joint association with Leiutis and Biophore for therapeutics
The partnership leverages the strengths of each of the companies resulting in an innovation strategy creating a unique value proposition to doctors and patients in India
Global Pharma | 01/12/2022 | By Sudeep Soparkar | 1462
The event witnessed 50,000 visitors from across the globe, more than 1,500 exhibitors and representation from over 80 countries
Global Pharma | 30/11/2022 | By Sudeep Soparkar | 608
Lupins' Brazilian arm buys nine brand rights from Bausch Health
Medqumica develops an extensive line of both solid and liquid medicines in Brazil
Global Pharma | 29/11/2022 | By Sudeep Soparkar | 968
Glenmark Pharma in agreement with Pfizer for Axitinib tabs, 1 mg and 5 mg
The Inlyta tablets, 1 mg and 5 mg market 2 achieved annual sales of approximately $644.5 million
Global Pharma | 22/11/2022 | By Sudeep Soparkar | 814
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy